As Featured In
The RESP® Platform: Connected Devices

RESP® Biosensor
First-of-its-kind wearable for high-fidelity monitoring of cough and lung sounds

Watch-Based Monitoring
Watch-based technology for targeted applications of cough monitoring
How it Works
An end-to-end system for flexible, comprehensive respiratory monitoring

Connected Devices
Patients or subjects continuously wear devices

RESP® Cloud
Data wirelessly transferred to the cloud for overread and analysis

Patient Reports
Strados provides reports to research or clinical teams
Why the RESP® Platform for Your Patients?
Privacy-Preserving
HIPAA compliant, incorporating advanced noise filtering and other techniques to preserve patient privacy
Designed for Daily Life
Wireless, discreet devices that don’t interfere with daily life and routines
Global Experience
Used by patients and subjects in five continents, 34 countries and 234 sites
Multi-Parameter
A comprehensive, robust combination of digital measures for greater insight into respiratory status
Medical Grade
Validated against gold standards including widely used electronic stethoscopes
FAQ
Frequently Asked Questions and Technical Specifications
News & Resources
Cough Intensity: A Novel Measure of Cough Burden
This whitepaper explores an important but historically under-measured dimension of cough burden: cough intensity. While cough frequency is the traditional metric used to objectively measure cough burden, it is limited in its ability to capture only how often a patient...
Data Processing Architectures for Cough Monitoring: The Case for Cloud Processing
This whitepaper highlights an important yet often overlooked aspect of cough monitoring: the data processing architecture that supports how cough events are detected and reported in clinical trials. As pharmaceutical sponsors increasingly include cough as a digital...
Strados Labs Collaborates with Rutgers Robert Wood Johnson Medical School, RWJBarnabas Health to Evaluate Wearable Respiratory Monitoring in Cystic Fibrosis
The pilot study explores the RESP® Biosensor’s potential to allow for low-effort home monitoring in patients with acute and chronic cystic fibrosis. Philadelphia, PA, August 28th, 2025 — Strados Labs, a digital health company advancing respiratory health through...
Let's Talk
Speak to one of our respiratory experts to learn more


